Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram for symptoms and utilization in ACS
NCT01667744Phase 2Withdrawn
- Sponsor
- Henry Ford Health
- Start
- Jan 2016
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of citalopram in acute coronary syndrome (ACS), sponsored by Henry Ford Health. Planned start Jan 2016; status: withdrawn.
02
Drugs
citalopram
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT01667744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01667744.